Currently, there is a lack of measures specifically developed and tailored for the PHTS population. The high prevalence of neurodevelopmental and neuropsychiatric symptoms in this clinically diverse population, together with the significant negative impact on affected individuals and their families, makes this particular manifestation a key target for the development of improved clinical measures.
New tools should be optimised for screening, diagnosis, treatment outcome monitoring and neurobiological investigations in this population. An additional challenge for rare conditions, such as PHTS, is that people with the condition are often geographically distant from specialist research centres, so remote tools are highly desirable.
Project title: Development and Validation of a Neurobehavioural Evaluation Tool for PHTS
Type of study: Clinical outcome measures
Lead researcher: Professor Thomas Frazier
Institution: John Carroll University, Ohio, USA
Project start: February 2021 Completed: September 2024
To develop and validate brief clinical outcome measures that can appropriately assess the broad neurobehavioural phenotype associated with PHTS in the family home.
In this project, Prof Thomas Frazier’s team developed and validated a web-based clinical outcome assessment designed specifically for people with PHTS. The project has two parts - caregiver completed surveys called the neurobehavioural evaluation tool (NET) and webcam-collected performance measures to facilitate remote capture of key neurobehavioural information from individuals with PHTS.
Recruitment of families for the survey scale and webcam-collected performance measures took place in the USA and UK (NCT05671107) and has now been completed.
The following publications have resulted from work associated with this grant:
In 2025, the NET tool and webcam performance measure have been accepted into the FDA Rare Disease Endpoint Advancement Pilot Programme (RDEA).